CI Investments Inc
TEVA icon

CI Investments Inc’s Teva Pharmaceuticals TEVA Stock Holding History

CI Investments Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$202K – 1191
2025
Q3 		$202K Hold
10,000
– – ﹤0.01% 705
2025
Q2 		$168K Buy
+10,000
New +$161K ﹤0.01% 756
2022
Q4 		– Sell
-26,786
Closed -$216K – 1365
2022
Q3 		$216K Sell
26,786
-8,691
-24% -$76.8K ﹤0.01% 580
2022
Q2 		$267K Sell
35,477
-10,460
-23% -$91.1K ﹤0.01% 556
2022
Q1 		$431K Sell
45,937
-7,219
-14% -$60.2K ﹤0.01% 556
2021
Q4 		$426K Buy
53,156
+4,708
+10% +$42.5K ﹤0.01% 628
2021
Q3 		$472K Sell
48,448
-4,238
-8% -$39.7K ﹤0.01% 613
2021
Q2 		$522K Buy
52,686
+10,626
+25% +$112K ﹤0.01% 623
2021
Q1 		$485K Buy
42,060
+1,141
+3% +$13.1K ﹤0.01% 560
2020
Q4 		$395K Buy
40,919
+10,657
+35% +$102K ﹤0.01% 571
2020
Q3 		$273K Buy
30,262
+7,339
+32% +$77.6K ﹤0.01% 522
2020
Q2 		$283K Buy
+22,923
New +$259K ﹤0.01% 484
2016
Q4 		– Sell
-369,900
Closed -$17M – 222
2016
Q3 		$17M Sell
369,900
-350,700
-49% -$18.3M 0.19% 112
2016
Q2 		$36.2M Sell
720,600
-18,500
-3% -$985K 0.41% 71
2016
Q1 		$39.5M Sell
739,100
-17,689
-2% -$1.04M 0.5% 58
2015
Q4 		$49.7M Buy
+756,789
New +$46.8M 0.63% 50

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

CI Investments Inc's TEVA Position: Q4 2025 in Review

CI Investments Inc sold out of Teva Pharmaceuticals (TEVA) in Q4 2025, closing a stake of 10,000 shares — an estimated $202K sold.

CI Investments Inc first reported a position in TEVA in Q4 2015 and held it in 16 quarters. The position peaked at $49.7M in Q4 2015. 631 funds tracked by Wall St. Rank hold TEVA as of Q4 2025.

  • CI Investments Inc reported no remaining Teva Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • CI Investments Inc sold 10,000 Teva Pharmaceuticals shares in Q4 2025, an estimated $202K.
  • CI Investments Inc first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 16 quarters.
  • CI Investments Inc's Teva Pharmaceuticals position peaked at $49.7M in Q4 2015.
  • 631 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2025.

Based on CI Investments Inc's 13F filing for Q4 2025, filed 12 Feb 2026.